Skip to content

Clinical trials

Schizophrenia trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Argentina Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20065
20074
20084
20091
20102
20112
20123
20131
20141
20172
20191
20201
20214
20222
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting4
Terminated4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Janssen Research & Development, LLC4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Boehringer Ingelheim3
FORUM Pharmaceuticals Inc3
Hoffmann-La Roche3
ACADIA Pharmaceuticals Inc.2
Alkermes, Inc.2
Solvay Pharmaceuticals2
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia39
Psychotic Disorders6
Cognition Disorders3
Bipolar Disorder1
Body Weight Changes1
Depressive Disorder1
Schizophrenia, Treatment-Resistant1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.